Beyond amyloid: a diverse portfolio of novel drug discovery programs for Alzheimer's disease and related dementias.
Alzheimers Res Ther
; 3(6): 36, 2011 Dec 15.
Article
em En
| MEDLINE
| ID: mdl-22236739
ABSTRACT
Although the molecular mechanisms underlying the pathogenesis of Alzheimer's disease and other related neurodegenerative diseases remain unclear, accumulation of misfolded proteins, neuroinflammation, mitochondrial dysfunction and perturbed calcium homeostasis have been identified as key events leading to neuronal loss during neurodegeneration. Evidence for 'druggable' targets for each of these key mechanisms was presented by the Alzheimer's Drug Discovery Foundation-funded investigators at the 12th International Conference on Alzheimer's Drug Discovery, Jersey City, NJ, 26-27 September 2011 http//www.worldeventsforum.com/addf/addrugdiscovery.
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Revista:
Alzheimers Res Ther
Ano de publicação:
2011
Tipo de documento:
Article
País de afiliação:
Estados Unidos